Received Aug 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | 2 | f4ac3 | IM / LA |
I haven't been able to get in touch with this patient yet. I will update once I am able to speak with her to detail whether she had any adverse reactions or not. It came to our attention after the fact that this was a duplication of the RSV vaccine. She had indicated that she hadn't yet received it and there was no record in our state immunization registry. After the fact we received a report from our Rx processing software indicating that it was duplicated.